Depsipeptide (Romidepsin) in Treating Patients With Metastatic or Unresectable Soft Tissue Sarcoma
Status:
Completed
Trial end date:
2008-10-23
Target enrollment:
Participant gender:
Summary
This phase II trial studies how well depsipeptide (romidepsin) works in treating patients
with metastatic or unresectable soft tissue sarcoma. Drugs used in chemotherapy, such as
depsipeptide, work in different ways to stop the growth of tumor cells, either by killing the
cells or by stopping them from dividing.